Clinical Utility of the Apolipoprotein <scp>A2</scp> Isoform Index as a Tumor Marker for Pancreatic Cancer
The apoA2-i index can detect CA19-9-negative pancreatic cancer, and the combination of the apoA2-i index with CA19-9 enhances diagnostic performance in clinical practice.
Authors
- Takeshi Hatanaka (ORCID: https://orcid.org/0000-0003-3656-285X)
- Satoru Kakizaki (ORCID: https://orcid.org/0000-0002-1508-584X)
- Takashi Hoshino (ORCID: https://orcid.org/0000-0002-9364-9030)
- Atsushi Naganuma
- Shomei Ryozawa
- Masafumi Mizuide
- Yuhei Suzuki
- Hidetoshi Yasuoka
Institutions
- National Hospital Organization Takasaki Medical Center (JP)
- Gunma Saiseikai Maebashi Hospital (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- JGH Open
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1002/jgh3.70375
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00